Viewing a single comment thread. View all comments

Silpion t1_it84ql5 wrote

Injecting the source as a liquid solution that hardens inside the body isn't novel?

4

R1ckMartel t1_it85txq wrote

There are numerous targeted molecular therapies with radiopharmaceuticals that would achieve precise localization to the tumor when attached to a ligand and chelating molecule. Hardening is irrelevant.

Lutathera is a prime example.

Why they choose I-131 is bizarre to me. It has a more mixed emission spectrum (a 364 kEV gamma) that would irradiate more of the surrounding, healthy tissue than other agents like Lutetium-177 that are almost pure beta-emitters.

3